May 14, 2019
Japanese generic major Nichi-Iko Pharmaceutical said on May 13 that it will sell part of its shareholding in South Korean partner Aprogen in two tranches, while maintaining their capital and business alliance clinched in 2010 for their collaboration in biosimilar...read more